coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Bolton Central PCN, Bolton (LAD) · Health Inequalities Profile

    PCN U65316 · NHS Greater Manchester Integrated Care Board · 13 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    52,201

    Registered population

    62.4% aged 18–64

    8.8%

    Aged 65+

    ICB 14.9% · England 17.9%

    61.9%

    Ethnic minority (non-White)

    47.5% Asian · England 9.6%

    87.7%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~33,968

    Core20 residents (est.)

    Resident basis; registered basis ~47,505 · see page 3

    5,531

    Hypertension register

    +3.89% in 3 yrs · England +5.60%

    592

    SMI register

    16.3% of Bolton (LAD)'s

    662

    COPD register

    Reviews +5.14% in 3 yrs

    Forecast to 2030

    6,205

    Hypertension patients, 2030

    +674 on today

    73.8%

    QRISK ≥20% on statins, 2030

    +0.56pp over 3 yrs

    1.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.3%
    Breast and cervical screening trail England.

    Breast screening is 57.3% (England 69.9%) and cervical screening ages 25-49 is 56.5% (England 66.8%), which may reflect unverified recall or access barriers.

    81.5%
    Pre-school booster lags the 95.0% target.

    Age-5 4-in-1 coverage is 81.5% (13.5 pp below the 95.0% target) and MMR2 is 87.6% despite 97.0% MMR1, which may indicate follow-up gaps.

    89.8%
    Chronic disease register reviews exceed England.

    Heart failure reviews reach 89.8% (England 78.5%), COPD reviews 87.3% (England 76.4%) and QRISK ≥ 20% lipid therapy 72.7% (England 63.6%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Bolton Central PCN has a young profile and a 47.5% Asian resident share

    Bolton Central PCN serves 52,201 registered patients. Children aged 0–17 comprise 28.8% of the list (15,047 patients), above Bolton (LAD) (23.7%), NHS Greater Manchester Integrated Care Board (21.8%) and England (19.6%). Patients aged 65+ account for 8.8% (4,592 patients), below Bolton (LAD) (14.7%), the ICB (14.9%) and England (17.9%). Census usual residents in associated areas are 47.5% Asian / Asian British (England 9.6%) and 38.1% White (England 81.1%). The younger age structure may influence crude chronic disease registers, which local age-stratified reviews can test.

    Age profile

    0–1728.8%
    18–6462.4%
    65+8.8%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    Asian47.5%
    White38.1%
    Black7.9%
    Other4.2%
    Mixed2.3%

    Older people · falls rows are Bolton (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bolton LA)1,9232,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)51.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bolton LA)9581,0219552024/25
    Falls deaths, all ages, per 100,000 (Bolton LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients comprise 87.7% of the PCN, with average IMD decile 2.0

    The PCN has 87.7% of registered patients in the Core20 cohort, compared with 47.8% in Bolton (LAD), 40.7% in NHS Greater Manchester Integrated Care Board and 21.0% in England, with an average IMD decile of 2.0 (England 5.5). Practice concentration spans 31.5 pp, from Bradford Street Surgery at 68.5% to Deane Medical Centre at 100.0%. Practice-level registered Core20 estimates sum to 47,505 patients, whereas resident deciles 1 and 2 total 33,968. Resource allocation requires reconciling registered patient estimates with resident counts to target high-volume practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Deane100.0% · 3,672 patients
    Dr S Naseef100.0% · 2,039 patients
    Great Lever One100.0% · 2,444 patients
    3d100.0% · 1,574 patients
    Bolton General100.0% · 7,734 patients
    Olive97.3% · 5,442 patients
    Bolton89.7% · 6,973 patients
    Lever Chambers 289.6% · 3,494 patients
    Al Fal Medical89.4% · 4,378 patients
    Orient House83.7% · 2,872 patients
    Deane Clinic 177.6% · 2,742 patients
    Beehive76.7% · 2,799 patients
    Bradford Street68.5% · 1,342 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    592

    SMI register

    1.11% recorded prevalence

    331

    Learning disability register

    0.62% recorded prevalence

    22

    Care homes, 702 beds

    In the PCN catchment

    9.8%

    Provide unpaid care

    Bolton (LAD), Census 2021

    Recorded severe mental illness includes 592 patients (1.1%, above England's 1.0%), while learning disability prevalence is 0.6% (331 patients, matching England). The catchment includes 22 care homes with 702 beds. Borough-level carers (9.8%) and rough sleeping (5) cannot be directly extrapolated. The SMI register slightly exceeds England, so maintaining proactive physical health checks and coordinating care home reviews represent the primary vulnerable-group workload to prioritise.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 86.0% (England 83.4%) and BMI recording reached 86.6% (England 82.1%). Three-year BMI recording rose +0.8 pp, trailing England's +5.1 pp rise. Slower progress may indicate momentum loss across physical health checks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,531

    Hypertension register

    +3.89%

    Register growth, 3 yrs

    Bolton (LAD) +4.70% · England +5.60%

    −2.39pp

    BP control, under 80

    ≤140/90 · +0.71pp aged 80+

    +674

    More patients by 2030

    Forecast 6,205 (11.17%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 10.3% (5,531 patients), below England (15.2%), Bolton (14.8%) and NHS Greater Manchester ICB (14.4%), though crude registers are unadjusted for age. Blood pressure control exceeds benchmarks, with 71.7% treated to target (England 70.3%) and 70.2% aged under 80 at <= 140/90 mmHg (England 67.8%). However, achievement for under-80s fell 3.3% over three years while England rose +3.2%, Bolton rose +1.0% and the ICB rose +3.6%. Slipping control for patients aged under 80 indicates an emerging gap in maintenance that systematic recall can address.

    Lipids and statins

    Patients with QRISK >= 20% receiving lipid-lowering therapy reach 72.7% (England 63.6%, Bolton 63.0%, ICB 67.0%), while diabetes primary prevention statin coverage sits at 78.8% (England 73.2%). High coverage is consistent with strong initiation; practices can focus on sustaining reviews.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202680,377£1.60£1.94£1.86£128,603
    Cardiovascular (all), 2025105,903£2.81£3.15£3.33£297,587

    For lipid-regulating drugs 2026, the PCN prescribed 80,377 items at £1.60 per item, below England (£1.86), Bolton (£1.81) and NHS Greater Manchester ICB (£1.94), spending £20,898 less than at England's unit cost across 80,377 items. Prescribing unit costs sit below comparators, representing lower expenditure per item rather than verified prescribing efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −1.00%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −2.41%

    Asthma prevalence, PCN 3-yr % change

    Recorded COPD prevalence is 1.2% (662 patients; England 1.9%) and asthma prevalence is 5.1% (2,493 patients; England 6.6%). Annual reviews reach 87.3% for COPD (England 76.4%) and 77.3% for asthma (England 65.7%), with youth second-hand smoke recording at 89.4% (England 78.8%). However, asthma review coverage fell 1.0% over three years (England +4.4%), leaving about 570 unreviewed patients. Youth asthma prescribing of 1,345 items per 1,000 (Bolton 2,033) is lower than borough rates; clinical audit would test diagnostic variation.

    Cancer register and children's immunisation

    Cancer QOF prevalence (all ages) is 1.4% at PCN level, below Bolton (LAD) (3.2%), NHS Greater Manchester Integrated Care Board (3.3%) and England (3.8%). Crude prevalence differences do not establish under-detection or unmet need; demographic factors and coding practices require local clinical verification.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.0%

    England 91.0%

    6-in-1 complete primary course at 24 months94.4%

    England 92.2%

    MMR dose 1 at 24 months90.1%

    England 88.3%

    MMR dose 2 at age 587.6%

    England 82.8%

    4-in-1 pre-school booster at age 581.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of cancers with a known stage in NHS Greater Manchester ICB were diagnosed at stage 1 or 2 (6,491 of 11,679 staged cases; England 55.3%), standing 19.4 pp below the 75.0% national ambition. Known stage was recorded for 70.8% (11,679 of 16,492). Reaching 75.0% requires about 2,270 extra early diagnoses annually across the ICB. For the PCN, breast screening is 57.3% (Bolton 71.2%, England 69.9%) and cervical screening for ages 25–49 is 56.5% (England 66.8%), falling 3.0% over three years (England -1.0%). Crude cancer prevalence is 1.4% (England 3.8%). Screening uptake lags comparators, which clinical review can investigate.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Pathways within standard (%)BoltonNorthern Care AllianceWrightington, Wigan and LeighGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4875.2082.8079.5379.32
    31-day treatment (96%)96.5094.5489.0496.4992.50
    62-day referral to treatment (85%)69.6678.6576.7875.7371.16
    Diagnostic waits over 6 weeks (%)BoltonNorthern Care AllianceWrightington, Wigan and LeighEngland
    MRI2.055.090.4921.40
    CT19.404.107.789.92
    Echocardiography3.4831.4824.3728.48
    Colonoscopy1.3340.046.1030.83
    Gastroscopy2.0636.4812.5429.02
    All 15 DM01 tests15.7815.7114.3623.14
    Community services activityBolton residentsGreater Manchester ICB
    Care contacts49,315573,310
    Referrals4,07594,470
    Patients with a contact17,765183,535

    Community services (residents of Bolton), Jun 2026 (provisional). In provisional Community Services Dataset records for June 2026, 51.6% of community contacts with Bolton borough residents were with adults aged 65 and over (25,460 of 49,315 contacts). Community provision heavily serves older residents, highlighting the need to coordinate neighbourhood care with secondary cancer and chronic disease services.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Dr S Naseef95100.087.7%81.9%93.0%
    Bradford Street7968.585.3%59.7%89.2%
    Orient House8383.780.1%81.7%85.9%
    Bolton8689.770.1%63.9%81.2%
    Lever Chambers 28789.664.6%76.8%81.1%
    Deane81100.064.0%73.7%78.5%
    Bolton General63100.062.1%68.7%78.2%
    Olive6897.375.1%85.3%75.7%
    Great Lever One87100.063.4%68.8%71.6%
    Beehive Surgery7776.752.6%78.3%69.3%
    3d Medical Centre42100.081.5%90.6%65.8%
    Al Fal Medical9189.445.4%79.1%61.4%
    Deane Clinic 113077.662.5%65.6%61.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBolton (LAD)AssetPCNBolton (LAD)
    Care homes (catchment)22 (702 beds)n/aSchools (catchment)73n/a
    Children's centres618Places of worship53144
    Libraries17Primary schools (LA maintained)1761
    Primary academies932Special schools13

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Culturally adapted cancer screening recall

    Breast screening coverage (aged 53 to 70) is 57.3% (England 69.9%, Bolton (LAD) 71.2%; difference vs England -12.6 percentage points) and cervical screening (aged 25 to 49, in the last 3.5 yrs) is 56.5% (England 66.8%; difference vs England -10.4 percentage points, with a 3-year change of -3.0% from 2023. Moderate effort to run.

    Evidence base: uptake is the delivery measure of the national cancer screening programme; distance to the acceptable and achievable standards is the outreach target.

    Policy anchor: Shift 3: sickness to prevention; Eliminate cervical cancer by 2040.

    Option 2

    Pre-school booster and MMR2 recall

    In Q1 2025/26 (cohort 230), age-5 4-in-1 coverage is 81.5% (13.5 pp below 95.0%; England 80.9%), while MMR2 is 87.6% (9.4 pp below MMR1 at 97.0%). For discussion: practices could run targeted recall for children with MMR1 but no recorded MMR2 or 4-in-1 booster, offering flexible clinic slots. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Structured annual asthma review recall

    Asthma review coverage is 77.3% (above England's 65.7%) on a 2,493-patient register, leaving a scale indicator of about 570 unreviewed patients, while three-year coverage fell 1.0% (England +4.4%). For discussion: practices could standardise annual asthma review templates and offer after-school or holiday slots alongside inhaler prescribing checks. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally adapted outreach review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Core20 list and volume reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check review (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Targeted screening uptake recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Culturally adapted cancer screening recall (p12)Breast screening coverage: aged 53 to 70 years old · Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) · Asian / Asian BritishFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 2 · Pre-school booster and MMR2 recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15